BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210918T060000
DTEND;TZID=America/Vancouver:20210919T180000
DTSTAMP:20260404T185317
CREATED:20210825T195313Z
LAST-MODIFIED:20210825T195313Z
UID:18008-1631944800-1632074400@scienceinvancouver.com
SUMMARY:“I Move for Immigrant Women in Science” 2021
DESCRIPTION:To say bye to the hot summer and welcome the Fall season\, IWS is organizing a virtual fundraising campaign\, ‘I move for Immigrant Women in Science’ that will take place from September 18th to 26th. \nThe IWS network has always been the torchbearer to build a collaborative network that supports and promotes equity\, diversity\, and inclusion of Immigrant and International Women from STEM backgrounds in Canada. \nThe event offers the opportunity for everyone to participate across Canada in their comfort zone. Over a week\, participants can choose any mode of motion as they wish. You can skip\, hop\, run\, jog\, bike or even row! Activity and distance is yours to choose. \nParticipants will need to register and purchase tickets through Eventbrite. Tickets may be purchased for $5\, $10\, $15\, $20 and $25. Please do note that the distance you ‘move’ is equivalent to the ticket purchased. For example\, if you decide to move 10kms\, you are buying a ticket for $10. \nThe funds raised will help us to support our operations\, outreach\, and develop new programs. Any small help can make a big difference! \nAre you ready to take up the challenge to support the future of immigrant women in STEM? \nOnce you are registered through Eventbrite\, you will receive an order confirmation. Please note that this is not a competition and we will not have any rankings. \nEverybody will be acknowledged on our Social Media platforms (Twitter\, Linked In\, Facebook). Thus\, as soon as you complete your ‘move’\, email us a picture/selfie or screenshot from your device at: iws.fundraising@gmail.com\, or you can post a picture/selfie on Social Media channels and tag us! (Optional). \n“Let’s Move Together to Support Each Other” for IWS! Everybody is welcome to join! \n#Imove4ImmigrantWomeninScience \n#immigrantwomeninscience \n#Imove4IWSnetwork \n@IWS_Network (Twitter); and @IWSNetworkCanada (Facebook) \nThank you and happy moving! \nIWS-Network
URL:https://scienceinvancouver.com/event/i-move-for-immigrant-women-in-science-2021/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/i-move-for-immigrant-women-in-science.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210918T060000
DTEND;TZID=America/Vancouver:20210919T180000
DTSTAMP:20260404T185317
CREATED:20210825T195313Z
LAST-MODIFIED:20210825T195313Z
UID:26427-1631944800-1632074400@scienceinvancouver.com
SUMMARY:“I Move for Immigrant Women in Science” 2021
DESCRIPTION:To say bye to the hot summer and welcome the Fall season\, IWS is organizing a virtual fundraising campaign\, ‘I move for Immigrant Women in Science’ that will take place from September 18th to 26th. \nThe IWS network has always been the torchbearer to build a collaborative network that supports and promotes equity\, diversity\, and inclusion of Immigrant and International Women from STEM backgrounds in Canada. \nThe event offers the opportunity for everyone to participate across Canada in their comfort zone. Over a week\, participants can choose any mode of motion as they wish. You can skip\, hop\, run\, jog\, bike or even row! Activity and distance is yours to choose. \nParticipants will need to register and purchase tickets through Eventbrite. Tickets may be purchased for $5\, $10\, $15\, $20 and $25. Please do note that the distance you ‘move’ is equivalent to the ticket purchased. For example\, if you decide to move 10kms\, you are buying a ticket for $10. \nThe funds raised will help us to support our operations\, outreach\, and develop new programs. Any small help can make a big difference! \nAre you ready to take up the challenge to support the future of immigrant women in STEM? \nOnce you are registered through Eventbrite\, you will receive an order confirmation. Please note that this is not a competition and we will not have any rankings. \nEverybody will be acknowledged on our Social Media platforms (Twitter\, Linked In\, Facebook). Thus\, as soon as you complete your ‘move’\, email us a picture/selfie or screenshot from your device at: iws.fundraising@gmail.com\, or you can post a picture/selfie on Social Media channels and tag us! (Optional). \n“Let’s Move Together to Support Each Other” for IWS! Everybody is welcome to join! \n#Imove4ImmigrantWomeninScience \n#immigrantwomeninscience \n#Imove4IWSnetwork \n@IWS_Network (Twitter); and @IWSNetworkCanada (Facebook) \nThank you and happy moving! \nIWS-Network
URL:https://scienceinvancouver.com/event/i-move-for-immigrant-women-in-science-2021-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/i-move-for-immigrant-women-in-science.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210918T060000
DTEND;TZID=America/Vancouver:20210919T180000
DTSTAMP:20260404T185317
CREATED:20210825T195313Z
LAST-MODIFIED:20210825T195313Z
UID:28042-1631944800-1632074400@scienceinvancouver.com
SUMMARY:“I Move for Immigrant Women in Science” 2021
DESCRIPTION:To say bye to the hot summer and welcome the Fall season\, IWS is organizing a virtual fundraising campaign\, ‘I move for Immigrant Women in Science’ that will take place from September 18th to 26th. \nThe IWS network has always been the torchbearer to build a collaborative network that supports and promotes equity\, diversity\, and inclusion of Immigrant and International Women from STEM backgrounds in Canada. \nThe event offers the opportunity for everyone to participate across Canada in their comfort zone. Over a week\, participants can choose any mode of motion as they wish. You can skip\, hop\, run\, jog\, bike or even row! Activity and distance is yours to choose. \nParticipants will need to register and purchase tickets through Eventbrite. Tickets may be purchased for $5\, $10\, $15\, $20 and $25. Please do note that the distance you ‘move’ is equivalent to the ticket purchased. For example\, if you decide to move 10kms\, you are buying a ticket for $10. \nThe funds raised will help us to support our operations\, outreach\, and develop new programs. Any small help can make a big difference! \nAre you ready to take up the challenge to support the future of immigrant women in STEM? \nOnce you are registered through Eventbrite\, you will receive an order confirmation. Please note that this is not a competition and we will not have any rankings. \nEverybody will be acknowledged on our Social Media platforms (Twitter\, Linked In\, Facebook). Thus\, as soon as you complete your ‘move’\, email us a picture/selfie or screenshot from your device at: iws.fundraising@gmail.com\, or you can post a picture/selfie on Social Media channels and tag us! (Optional). \n“Let’s Move Together to Support Each Other” for IWS! Everybody is welcome to join! \n#Imove4ImmigrantWomeninScience \n#immigrantwomeninscience \n#Imove4IWSnetwork \n@IWS_Network (Twitter); and @IWSNetworkCanada (Facebook) \nThank you and happy moving! \nIWS-Network
URL:https://scienceinvancouver.com/event/i-move-for-immigrant-women-in-science-2021-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/i-move-for-immigrant-women-in-science.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210918T060000
DTEND;TZID=America/Vancouver:20210919T180000
DTSTAMP:20260404T185317
CREATED:20210825T195313Z
LAST-MODIFIED:20210825T195313Z
UID:31125-1631944800-1632074400@scienceinvancouver.com
SUMMARY:“I Move for Immigrant Women in Science” 2021
DESCRIPTION:To say bye to the hot summer and welcome the Fall season\, IWS is organizing a virtual fundraising campaign\, ‘I move for Immigrant Women in Science’ that will take place from September 18th to 26th. \nThe IWS network has always been the torchbearer to build a collaborative network that supports and promotes equity\, diversity\, and inclusion of Immigrant and International Women from STEM backgrounds in Canada. \nThe event offers the opportunity for everyone to participate across Canada in their comfort zone. Over a week\, participants can choose any mode of motion as they wish. You can skip\, hop\, run\, jog\, bike or even row! Activity and distance is yours to choose. \nParticipants will need to register and purchase tickets through Eventbrite. Tickets may be purchased for $5\, $10\, $15\, $20 and $25. Please do note that the distance you ‘move’ is equivalent to the ticket purchased. For example\, if you decide to move 10kms\, you are buying a ticket for $10. \nThe funds raised will help us to support our operations\, outreach\, and develop new programs. Any small help can make a big difference! \nAre you ready to take up the challenge to support the future of immigrant women in STEM? \nOnce you are registered through Eventbrite\, you will receive an order confirmation. Please note that this is not a competition and we will not have any rankings. \nEverybody will be acknowledged on our Social Media platforms (Twitter\, Linked In\, Facebook). Thus\, as soon as you complete your ‘move’\, email us a picture/selfie or screenshot from your device at: iws.fundraising@gmail.com\, or you can post a picture/selfie on Social Media channels and tag us! (Optional). \n“Let’s Move Together to Support Each Other” for IWS! Everybody is welcome to join! \n#Imove4ImmigrantWomeninScience \n#immigrantwomeninscience \n#Imove4IWSnetwork \n@IWS_Network (Twitter); and @IWSNetworkCanada (Facebook) \nThank you and happy moving! \nIWS-Network
URL:https://scienceinvancouver.com/event/i-move-for-immigrant-women-in-science-2021-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/i-move-for-immigrant-women-in-science.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210918T060000
DTEND;TZID=America/Vancouver:20210919T180000
DTSTAMP:20260404T185317
CREATED:20210825T195313Z
LAST-MODIFIED:20210825T195313Z
UID:32585-1631944800-1632074400@scienceinvancouver.com
SUMMARY:“I Move for Immigrant Women in Science” 2021
DESCRIPTION:To say bye to the hot summer and welcome the Fall season\, IWS is organizing a virtual fundraising campaign\, ‘I move for Immigrant Women in Science’ that will take place from September 18th to 26th. \nThe IWS network has always been the torchbearer to build a collaborative network that supports and promotes equity\, diversity\, and inclusion of Immigrant and International Women from STEM backgrounds in Canada. \nThe event offers the opportunity for everyone to participate across Canada in their comfort zone. Over a week\, participants can choose any mode of motion as they wish. You can skip\, hop\, run\, jog\, bike or even row! Activity and distance is yours to choose. \nParticipants will need to register and purchase tickets through Eventbrite. Tickets may be purchased for $5\, $10\, $15\, $20 and $25. Please do note that the distance you ‘move’ is equivalent to the ticket purchased. For example\, if you decide to move 10kms\, you are buying a ticket for $10. \nThe funds raised will help us to support our operations\, outreach\, and develop new programs. Any small help can make a big difference! \nAre you ready to take up the challenge to support the future of immigrant women in STEM? \nOnce you are registered through Eventbrite\, you will receive an order confirmation. Please note that this is not a competition and we will not have any rankings. \nEverybody will be acknowledged on our Social Media platforms (Twitter\, Linked In\, Facebook). Thus\, as soon as you complete your ‘move’\, email us a picture/selfie or screenshot from your device at: iws.fundraising@gmail.com\, or you can post a picture/selfie on Social Media channels and tag us! (Optional). \n“Let’s Move Together to Support Each Other” for IWS! Everybody is welcome to join! \n#Imove4ImmigrantWomeninScience \n#immigrantwomeninscience \n#Imove4IWSnetwork \n@IWS_Network (Twitter); and @IWSNetworkCanada (Facebook) \nThank you and happy moving! \nIWS-Network
URL:https://scienceinvancouver.com/event/i-move-for-immigrant-women-in-science-2021-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/i-move-for-immigrant-women-in-science.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T100000
DTSTAMP:20260404T185317
CREATED:20210908T215410Z
LAST-MODIFIED:20210913T173506Z
UID:18179-1632128400-1632132000@scienceinvancouver.com
SUMMARY:adMare's Global Leaders Series: Dr. George Church
DESCRIPTION:Join us on Monday\, September 20 for adMare’s Global Leaders webinar series\, featuring Dr. George Church from Harvard University. Dr. Church is a legend in the startup biotech space\, having launched 16 spinout companies in 2018 alone.
URL:https://scienceinvancouver.com/event/admares-global-leaders-series-dr-george-church/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/Dr-George-Church.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T100000
DTSTAMP:20260404T185317
CREATED:20210908T215410Z
LAST-MODIFIED:20210908T215410Z
UID:26430-1632128400-1632132000@scienceinvancouver.com
SUMMARY:adMare's Global Leaders Series: Dr. George Church
DESCRIPTION:Join us on Monday\, September 20 for adMare’s Global Leaders webinar series\, featuring Dr. George Church from Harvard University. Dr. Church is a legend in the startup biotech space\, having launched 16 spinout companies in 2018 alone.
URL:https://scienceinvancouver.com/event/admares-global-leaders-series-dr-george-church-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/Dr-George-Church.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T100000
DTSTAMP:20260404T185317
CREATED:20210908T215410Z
LAST-MODIFIED:20210908T215410Z
UID:28045-1632128400-1632132000@scienceinvancouver.com
SUMMARY:adMare's Global Leaders Series: Dr. George Church
DESCRIPTION:Join us on Monday\, September 20 for adMare’s Global Leaders webinar series\, featuring Dr. George Church from Harvard University. Dr. Church is a legend in the startup biotech space\, having launched 16 spinout companies in 2018 alone.
URL:https://scienceinvancouver.com/event/admares-global-leaders-series-dr-george-church-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/Dr-George-Church.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T100000
DTSTAMP:20260404T185317
CREATED:20210908T215410Z
LAST-MODIFIED:20210908T215410Z
UID:31128-1632128400-1632132000@scienceinvancouver.com
SUMMARY:adMare's Global Leaders Series: Dr. George Church
DESCRIPTION:Join us on Monday\, September 20 for adMare’s Global Leaders webinar series\, featuring Dr. George Church from Harvard University. Dr. Church is a legend in the startup biotech space\, having launched 16 spinout companies in 2018 alone.
URL:https://scienceinvancouver.com/event/admares-global-leaders-series-dr-george-church-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/Dr-George-Church.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T100000
DTSTAMP:20260404T185317
CREATED:20210908T215410Z
LAST-MODIFIED:20210908T215410Z
UID:32588-1632128400-1632132000@scienceinvancouver.com
SUMMARY:adMare's Global Leaders Series: Dr. George Church
DESCRIPTION:Join us on Monday\, September 20 for adMare’s Global Leaders webinar series\, featuring Dr. George Church from Harvard University. Dr. Church is a legend in the startup biotech space\, having launched 16 spinout companies in 2018 alone.
URL:https://scienceinvancouver.com/event/admares-global-leaders-series-dr-george-church-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/Dr-George-Church.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T103000
DTSTAMP:20260404T185317
CREATED:20210916T144447Z
LAST-MODIFIED:20210916T144447Z
UID:18350-1632128400-1632133800@scienceinvancouver.com
SUMMARY:TFRI Pan-Can Seminar Series: BC Cancer Centre for Lymphoid Cancer
DESCRIPTION:This inaugural series\, held every other month\, features TFRI-funded program and project leaders and trainees. \n9:00-9:02am: Welcome by Jim Woodgett\, TFRI President and Scientific Director \n9:02-9:04am: Welcome and Introduction by Marco Marra\, BC Node Leader and Director\, Canada’s Michael Smith Genome Sciences Centre \n9:05 -9:45am: Christian Steidl\, MD\, Research Director\, Centre for Lymphoid Cancer\, BC Cancer\, who will speak on: Introduction to BC Cancer’s Centre for Lymphoid Cancer and The tumour microenvironment of Hodgkin lymphoma at single cell resolution \nTalk overview: In Hodgkin lymphoma (HL)\, the malignant cells are outnumbered by a dominant tumour microenvironment composed of mostly infiltrating immune cells. Modern targeted and immunotherapeutic approaches\, including checkpoint inhibitors\, have proven highly effective; however\, mechanisms of action and treatment failure remain mostly unknown. Characterization of the TME using multiparametric single cell technologies\, such as multicolor immunohistochemistry\, flow-based mass cytometry\, imaging mass cytometry\, and single cell RNAseq have provided unprecedented insight into HL biology\, fueling hope for accelerated development of immunotherapies targeting the tumour microenvironment and predictive biomarker development. \n9:45-10:05am: Brett Collinge\, Graduate Student\, Department of Pathology and Laboratory Medicine\, University of British Columbia\, Scott lab\, Centre for Lymphoid Cancer\, who will speak on: New molecular taxonomies in aggressive B cell lymphomas \nTalk overview: While standard treatment with chemoimmunotherapy cures ~60% of aggressive B-cell lymphomas\, patients with tumours that progress or relapse after frontline therapy have dismal outcomes\, making the development of new treatment strategies a major priority. Recent advances in molecular testing have allowed us to recognize that lymphoma entities can be further refined by introduction of molecular taxonomies grouping patients with similar molecular features and responses to treatment. Integrating molecular diagnostics into the clinic offers a promising avenue for improving outcomes in aggressive B-cell lymphomas. \n10:05-10:25am: Christopher Rushton\, Graduate Student\, Molecular Biology and Biochemistry\, Simon Fraser University\, Morin lab\, who will speak on: Genomic analysis of relapsed-refractory diffuse large B cell lymphoma \nTalk overview: Despite a plethora of treatment options\, patients with relapsed-refractory DLBCL generally have poor outcomes\, and the biology of relapsed disease is poorly understood. We have collected and sequenced samples from patients with relapsed DLBCL to identify somatic mutations that are enriched at the time point of relapse. Comparison to matched pre-treatment tumours revealed evidence of constrained tumour evolution\, diverging biology of early and late relapses\, and mechanisms of treatment resistance. \n10:25-10:30am: Final questions and conclusion
URL:https://scienceinvancouver.com/event/tfri-pan-can-seminar-series-bc-cancer-centre-for-lymphoid-cancer/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/christain-steidl-terry-fox.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T103000
DTSTAMP:20260404T185317
CREATED:20210916T144447Z
LAST-MODIFIED:20210916T144447Z
UID:26436-1632128400-1632133800@scienceinvancouver.com
SUMMARY:TFRI Pan-Can Seminar Series: BC Cancer Centre for Lymphoid Cancer
DESCRIPTION:This inaugural series\, held every other month\, features TFRI-funded program and project leaders and trainees. \n9:00-9:02am: Welcome by Jim Woodgett\, TFRI President and Scientific Director \n9:02-9:04am: Welcome and Introduction by Marco Marra\, BC Node Leader and Director\, Canada’s Michael Smith Genome Sciences Centre \n9:05 -9:45am: Christian Steidl\, MD\, Research Director\, Centre for Lymphoid Cancer\, BC Cancer\, who will speak on: Introduction to BC Cancer’s Centre for Lymphoid Cancer and The tumour microenvironment of Hodgkin lymphoma at single cell resolution \nTalk overview: In Hodgkin lymphoma (HL)\, the malignant cells are outnumbered by a dominant tumour microenvironment composed of mostly infiltrating immune cells. Modern targeted and immunotherapeutic approaches\, including checkpoint inhibitors\, have proven highly effective; however\, mechanisms of action and treatment failure remain mostly unknown. Characterization of the TME using multiparametric single cell technologies\, such as multicolor immunohistochemistry\, flow-based mass cytometry\, imaging mass cytometry\, and single cell RNAseq have provided unprecedented insight into HL biology\, fueling hope for accelerated development of immunotherapies targeting the tumour microenvironment and predictive biomarker development. \n9:45-10:05am: Brett Collinge\, Graduate Student\, Department of Pathology and Laboratory Medicine\, University of British Columbia\, Scott lab\, Centre for Lymphoid Cancer\, who will speak on: New molecular taxonomies in aggressive B cell lymphomas \nTalk overview: While standard treatment with chemoimmunotherapy cures ~60% of aggressive B-cell lymphomas\, patients with tumours that progress or relapse after frontline therapy have dismal outcomes\, making the development of new treatment strategies a major priority. Recent advances in molecular testing have allowed us to recognize that lymphoma entities can be further refined by introduction of molecular taxonomies grouping patients with similar molecular features and responses to treatment. Integrating molecular diagnostics into the clinic offers a promising avenue for improving outcomes in aggressive B-cell lymphomas. \n10:05-10:25am: Christopher Rushton\, Graduate Student\, Molecular Biology and Biochemistry\, Simon Fraser University\, Morin lab\, who will speak on: Genomic analysis of relapsed-refractory diffuse large B cell lymphoma \nTalk overview: Despite a plethora of treatment options\, patients with relapsed-refractory DLBCL generally have poor outcomes\, and the biology of relapsed disease is poorly understood. We have collected and sequenced samples from patients with relapsed DLBCL to identify somatic mutations that are enriched at the time point of relapse. Comparison to matched pre-treatment tumours revealed evidence of constrained tumour evolution\, diverging biology of early and late relapses\, and mechanisms of treatment resistance. \n10:25-10:30am: Final questions and conclusion
URL:https://scienceinvancouver.com/event/tfri-pan-can-seminar-series-bc-cancer-centre-for-lymphoid-cancer-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/christain-steidl-terry-fox.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T103000
DTSTAMP:20260404T185317
CREATED:20210916T144447Z
LAST-MODIFIED:20210916T144447Z
UID:28051-1632128400-1632133800@scienceinvancouver.com
SUMMARY:TFRI Pan-Can Seminar Series: BC Cancer Centre for Lymphoid Cancer
DESCRIPTION:This inaugural series\, held every other month\, features TFRI-funded program and project leaders and trainees. \n9:00-9:02am: Welcome by Jim Woodgett\, TFRI President and Scientific Director \n9:02-9:04am: Welcome and Introduction by Marco Marra\, BC Node Leader and Director\, Canada’s Michael Smith Genome Sciences Centre \n9:05 -9:45am: Christian Steidl\, MD\, Research Director\, Centre for Lymphoid Cancer\, BC Cancer\, who will speak on: Introduction to BC Cancer’s Centre for Lymphoid Cancer and The tumour microenvironment of Hodgkin lymphoma at single cell resolution \nTalk overview: In Hodgkin lymphoma (HL)\, the malignant cells are outnumbered by a dominant tumour microenvironment composed of mostly infiltrating immune cells. Modern targeted and immunotherapeutic approaches\, including checkpoint inhibitors\, have proven highly effective; however\, mechanisms of action and treatment failure remain mostly unknown. Characterization of the TME using multiparametric single cell technologies\, such as multicolor immunohistochemistry\, flow-based mass cytometry\, imaging mass cytometry\, and single cell RNAseq have provided unprecedented insight into HL biology\, fueling hope for accelerated development of immunotherapies targeting the tumour microenvironment and predictive biomarker development. \n9:45-10:05am: Brett Collinge\, Graduate Student\, Department of Pathology and Laboratory Medicine\, University of British Columbia\, Scott lab\, Centre for Lymphoid Cancer\, who will speak on: New molecular taxonomies in aggressive B cell lymphomas \nTalk overview: While standard treatment with chemoimmunotherapy cures ~60% of aggressive B-cell lymphomas\, patients with tumours that progress or relapse after frontline therapy have dismal outcomes\, making the development of new treatment strategies a major priority. Recent advances in molecular testing have allowed us to recognize that lymphoma entities can be further refined by introduction of molecular taxonomies grouping patients with similar molecular features and responses to treatment. Integrating molecular diagnostics into the clinic offers a promising avenue for improving outcomes in aggressive B-cell lymphomas. \n10:05-10:25am: Christopher Rushton\, Graduate Student\, Molecular Biology and Biochemistry\, Simon Fraser University\, Morin lab\, who will speak on: Genomic analysis of relapsed-refractory diffuse large B cell lymphoma \nTalk overview: Despite a plethora of treatment options\, patients with relapsed-refractory DLBCL generally have poor outcomes\, and the biology of relapsed disease is poorly understood. We have collected and sequenced samples from patients with relapsed DLBCL to identify somatic mutations that are enriched at the time point of relapse. Comparison to matched pre-treatment tumours revealed evidence of constrained tumour evolution\, diverging biology of early and late relapses\, and mechanisms of treatment resistance. \n10:25-10:30am: Final questions and conclusion
URL:https://scienceinvancouver.com/event/tfri-pan-can-seminar-series-bc-cancer-centre-for-lymphoid-cancer-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/christain-steidl-terry-fox.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T103000
DTSTAMP:20260404T185317
CREATED:20210916T144447Z
LAST-MODIFIED:20210916T144447Z
UID:31134-1632128400-1632133800@scienceinvancouver.com
SUMMARY:TFRI Pan-Can Seminar Series: BC Cancer Centre for Lymphoid Cancer
DESCRIPTION:This inaugural series\, held every other month\, features TFRI-funded program and project leaders and trainees. \n9:00-9:02am: Welcome by Jim Woodgett\, TFRI President and Scientific Director \n9:02-9:04am: Welcome and Introduction by Marco Marra\, BC Node Leader and Director\, Canada’s Michael Smith Genome Sciences Centre \n9:05 -9:45am: Christian Steidl\, MD\, Research Director\, Centre for Lymphoid Cancer\, BC Cancer\, who will speak on: Introduction to BC Cancer’s Centre for Lymphoid Cancer and The tumour microenvironment of Hodgkin lymphoma at single cell resolution \nTalk overview: In Hodgkin lymphoma (HL)\, the malignant cells are outnumbered by a dominant tumour microenvironment composed of mostly infiltrating immune cells. Modern targeted and immunotherapeutic approaches\, including checkpoint inhibitors\, have proven highly effective; however\, mechanisms of action and treatment failure remain mostly unknown. Characterization of the TME using multiparametric single cell technologies\, such as multicolor immunohistochemistry\, flow-based mass cytometry\, imaging mass cytometry\, and single cell RNAseq have provided unprecedented insight into HL biology\, fueling hope for accelerated development of immunotherapies targeting the tumour microenvironment and predictive biomarker development. \n9:45-10:05am: Brett Collinge\, Graduate Student\, Department of Pathology and Laboratory Medicine\, University of British Columbia\, Scott lab\, Centre for Lymphoid Cancer\, who will speak on: New molecular taxonomies in aggressive B cell lymphomas \nTalk overview: While standard treatment with chemoimmunotherapy cures ~60% of aggressive B-cell lymphomas\, patients with tumours that progress or relapse after frontline therapy have dismal outcomes\, making the development of new treatment strategies a major priority. Recent advances in molecular testing have allowed us to recognize that lymphoma entities can be further refined by introduction of molecular taxonomies grouping patients with similar molecular features and responses to treatment. Integrating molecular diagnostics into the clinic offers a promising avenue for improving outcomes in aggressive B-cell lymphomas. \n10:05-10:25am: Christopher Rushton\, Graduate Student\, Molecular Biology and Biochemistry\, Simon Fraser University\, Morin lab\, who will speak on: Genomic analysis of relapsed-refractory diffuse large B cell lymphoma \nTalk overview: Despite a plethora of treatment options\, patients with relapsed-refractory DLBCL generally have poor outcomes\, and the biology of relapsed disease is poorly understood. We have collected and sequenced samples from patients with relapsed DLBCL to identify somatic mutations that are enriched at the time point of relapse. Comparison to matched pre-treatment tumours revealed evidence of constrained tumour evolution\, diverging biology of early and late relapses\, and mechanisms of treatment resistance. \n10:25-10:30am: Final questions and conclusion
URL:https://scienceinvancouver.com/event/tfri-pan-can-seminar-series-bc-cancer-centre-for-lymphoid-cancer-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/christain-steidl-terry-fox.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210920T090000
DTEND;TZID=America/Vancouver:20210920T103000
DTSTAMP:20260404T185317
CREATED:20210916T144447Z
LAST-MODIFIED:20210916T144447Z
UID:32594-1632128400-1632133800@scienceinvancouver.com
SUMMARY:TFRI Pan-Can Seminar Series: BC Cancer Centre for Lymphoid Cancer
DESCRIPTION:This inaugural series\, held every other month\, features TFRI-funded program and project leaders and trainees. \n9:00-9:02am: Welcome by Jim Woodgett\, TFRI President and Scientific Director \n9:02-9:04am: Welcome and Introduction by Marco Marra\, BC Node Leader and Director\, Canada’s Michael Smith Genome Sciences Centre \n9:05 -9:45am: Christian Steidl\, MD\, Research Director\, Centre for Lymphoid Cancer\, BC Cancer\, who will speak on: Introduction to BC Cancer’s Centre for Lymphoid Cancer and The tumour microenvironment of Hodgkin lymphoma at single cell resolution \nTalk overview: In Hodgkin lymphoma (HL)\, the malignant cells are outnumbered by a dominant tumour microenvironment composed of mostly infiltrating immune cells. Modern targeted and immunotherapeutic approaches\, including checkpoint inhibitors\, have proven highly effective; however\, mechanisms of action and treatment failure remain mostly unknown. Characterization of the TME using multiparametric single cell technologies\, such as multicolor immunohistochemistry\, flow-based mass cytometry\, imaging mass cytometry\, and single cell RNAseq have provided unprecedented insight into HL biology\, fueling hope for accelerated development of immunotherapies targeting the tumour microenvironment and predictive biomarker development. \n9:45-10:05am: Brett Collinge\, Graduate Student\, Department of Pathology and Laboratory Medicine\, University of British Columbia\, Scott lab\, Centre for Lymphoid Cancer\, who will speak on: New molecular taxonomies in aggressive B cell lymphomas \nTalk overview: While standard treatment with chemoimmunotherapy cures ~60% of aggressive B-cell lymphomas\, patients with tumours that progress or relapse after frontline therapy have dismal outcomes\, making the development of new treatment strategies a major priority. Recent advances in molecular testing have allowed us to recognize that lymphoma entities can be further refined by introduction of molecular taxonomies grouping patients with similar molecular features and responses to treatment. Integrating molecular diagnostics into the clinic offers a promising avenue for improving outcomes in aggressive B-cell lymphomas. \n10:05-10:25am: Christopher Rushton\, Graduate Student\, Molecular Biology and Biochemistry\, Simon Fraser University\, Morin lab\, who will speak on: Genomic analysis of relapsed-refractory diffuse large B cell lymphoma \nTalk overview: Despite a plethora of treatment options\, patients with relapsed-refractory DLBCL generally have poor outcomes\, and the biology of relapsed disease is poorly understood. We have collected and sequenced samples from patients with relapsed DLBCL to identify somatic mutations that are enriched at the time point of relapse. Comparison to matched pre-treatment tumours revealed evidence of constrained tumour evolution\, diverging biology of early and late relapses\, and mechanisms of treatment resistance. \n10:25-10:30am: Final questions and conclusion
URL:https://scienceinvancouver.com/event/tfri-pan-can-seminar-series-bc-cancer-centre-for-lymphoid-cancer-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/09/christain-steidl-terry-fox.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T110000
DTSTAMP:20260404T185317
CREATED:20210908T224214Z
LAST-MODIFIED:20210908T224442Z
UID:18210-1632218400-1632222000@scienceinvancouver.com
SUMMARY:Lipid and RNA Nanomedicines to Control Bleeding and Thrombosis
DESCRIPTION:Dr. Christian Kastrup \nAssociate Professor in the Michael Smith Laboratories and Department of Biochemistry & Molecular Biology at the University of British Columbia; member of the Centre for Blood Research and the School of Biomedical Engineering \nTuesday 21 September 2021 \n10:00 – 11:00 am PDT | 1:00 – 2:00 pm EDT \nThis lecture will be delivered online using Zoom \nBlood coagulation is necessary to stop bleeds\, but an imbalance of the enzymes that form\, inhibit and degrade blood clots can lead to bleeding disorders\, failure to stop severe hemorrhage after injury\, or formation of thromboses. Gene therapy\, using RNA and lipid nanoparticles\, can be used to modulate the concentration of these enzymes and correct any imbalance. This talk will highlight the applicability of RNA and lipid nanoparticles to control the expression of endogenous and exogenous proteins in the liver and in platelets\, for the goal of creating useful therapies for trauma\, rare bleeding disorders\, and thrombosis. \nDr. Christian Kastrup did his postdoctoral fellowship in at MIT\, where he specialized in engineering biomaterials for cardiovascular drug delivery. He received his PhD at the University of Chicago\, where he specialized in chemical biology\, microfluidics\, and blood coagulation. His lab at UBC utilizes biochemical engineering to solve problems related to hemostasis and hemorrhage. They investigate\, utilize\, and mimic the biochemistry and biophysical dynamics of blood coagulation to create innovative materials that perform new functions inside of blood vessels\, and work to develop treatments for severe hemorrhage. \nDr. Kastrup has received many accolades\, the most recent one being the Sir Major Banting Award from the True Patriot Love Foundation. He is the Chief Scientific Officer of CoMotion Drug Delivery Systems\, Inc.\, which is working to develop hemostatic agents for severe combat and surgical hemorrhage.
URL:https://scienceinvancouver.com/event/lipid-and-rna-nanomedicines-to-control-bleeding-and-thrombosis/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T110000
DTSTAMP:20260404T185317
CREATED:20210908T224214Z
LAST-MODIFIED:20210908T224214Z
UID:26431-1632218400-1632222000@scienceinvancouver.com
SUMMARY:Lipid and RNA Nanomedicines to Control Bleeding and Thrombosis
DESCRIPTION:Dr. Christian Kastrup \nAssociate Professor in the Michael Smith Laboratories and Department of Biochemistry & Molecular Biology at the University of British Columbia; member of the Centre for Blood Research and the School of Biomedical Engineering \nTuesday 21 September 2021 \n10:00 – 11:00 am PDT | 1:00 – 2:00 pm EDT \nThis lecture will be delivered online using Zoom \nBlood coagulation is necessary to stop bleeds\, but an imbalance of the enzymes that form\, inhibit and degrade blood clots can lead to bleeding disorders\, failure to stop severe hemorrhage after injury\, or formation of thromboses. Gene therapy\, using RNA and lipid nanoparticles\, can be used to modulate the concentration of these enzymes and correct any imbalance. This talk will highlight the applicability of RNA and lipid nanoparticles to control the expression of endogenous and exogenous proteins in the liver and in platelets\, for the goal of creating useful therapies for trauma\, rare bleeding disorders\, and thrombosis. \nDr. Christian Kastrup did his postdoctoral fellowship in at MIT\, where he specialized in engineering biomaterials for cardiovascular drug delivery. He received his PhD at the University of Chicago\, where he specialized in chemical biology\, microfluidics\, and blood coagulation. His lab at UBC utilizes biochemical engineering to solve problems related to hemostasis and hemorrhage. They investigate\, utilize\, and mimic the biochemistry and biophysical dynamics of blood coagulation to create innovative materials that perform new functions inside of blood vessels\, and work to develop treatments for severe hemorrhage. \nDr. Kastrup has received many accolades\, the most recent one being the Sir Major Banting Award from the True Patriot Love Foundation. He is the Chief Scientific Officer of CoMotion Drug Delivery Systems\, Inc.\, which is working to develop hemostatic agents for severe combat and surgical hemorrhage.
URL:https://scienceinvancouver.com/event/lipid-and-rna-nanomedicines-to-control-bleeding-and-thrombosis-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T110000
DTSTAMP:20260404T185317
CREATED:20210908T224214Z
LAST-MODIFIED:20210908T224214Z
UID:28046-1632218400-1632222000@scienceinvancouver.com
SUMMARY:Lipid and RNA Nanomedicines to Control Bleeding and Thrombosis
DESCRIPTION:Dr. Christian Kastrup \nAssociate Professor in the Michael Smith Laboratories and Department of Biochemistry & Molecular Biology at the University of British Columbia; member of the Centre for Blood Research and the School of Biomedical Engineering \nTuesday 21 September 2021 \n10:00 – 11:00 am PDT | 1:00 – 2:00 pm EDT \nThis lecture will be delivered online using Zoom \nBlood coagulation is necessary to stop bleeds\, but an imbalance of the enzymes that form\, inhibit and degrade blood clots can lead to bleeding disorders\, failure to stop severe hemorrhage after injury\, or formation of thromboses. Gene therapy\, using RNA and lipid nanoparticles\, can be used to modulate the concentration of these enzymes and correct any imbalance. This talk will highlight the applicability of RNA and lipid nanoparticles to control the expression of endogenous and exogenous proteins in the liver and in platelets\, for the goal of creating useful therapies for trauma\, rare bleeding disorders\, and thrombosis. \nDr. Christian Kastrup did his postdoctoral fellowship in at MIT\, where he specialized in engineering biomaterials for cardiovascular drug delivery. He received his PhD at the University of Chicago\, where he specialized in chemical biology\, microfluidics\, and blood coagulation. His lab at UBC utilizes biochemical engineering to solve problems related to hemostasis and hemorrhage. They investigate\, utilize\, and mimic the biochemistry and biophysical dynamics of blood coagulation to create innovative materials that perform new functions inside of blood vessels\, and work to develop treatments for severe hemorrhage. \nDr. Kastrup has received many accolades\, the most recent one being the Sir Major Banting Award from the True Patriot Love Foundation. He is the Chief Scientific Officer of CoMotion Drug Delivery Systems\, Inc.\, which is working to develop hemostatic agents for severe combat and surgical hemorrhage.
URL:https://scienceinvancouver.com/event/lipid-and-rna-nanomedicines-to-control-bleeding-and-thrombosis-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T110000
DTSTAMP:20260404T185317
CREATED:20210908T224214Z
LAST-MODIFIED:20210908T224214Z
UID:31129-1632218400-1632222000@scienceinvancouver.com
SUMMARY:Lipid and RNA Nanomedicines to Control Bleeding and Thrombosis
DESCRIPTION:Dr. Christian Kastrup \nAssociate Professor in the Michael Smith Laboratories and Department of Biochemistry & Molecular Biology at the University of British Columbia; member of the Centre for Blood Research and the School of Biomedical Engineering \nTuesday 21 September 2021 \n10:00 – 11:00 am PDT | 1:00 – 2:00 pm EDT \nThis lecture will be delivered online using Zoom \nBlood coagulation is necessary to stop bleeds\, but an imbalance of the enzymes that form\, inhibit and degrade blood clots can lead to bleeding disorders\, failure to stop severe hemorrhage after injury\, or formation of thromboses. Gene therapy\, using RNA and lipid nanoparticles\, can be used to modulate the concentration of these enzymes and correct any imbalance. This talk will highlight the applicability of RNA and lipid nanoparticles to control the expression of endogenous and exogenous proteins in the liver and in platelets\, for the goal of creating useful therapies for trauma\, rare bleeding disorders\, and thrombosis. \nDr. Christian Kastrup did his postdoctoral fellowship in at MIT\, where he specialized in engineering biomaterials for cardiovascular drug delivery. He received his PhD at the University of Chicago\, where he specialized in chemical biology\, microfluidics\, and blood coagulation. His lab at UBC utilizes biochemical engineering to solve problems related to hemostasis and hemorrhage. They investigate\, utilize\, and mimic the biochemistry and biophysical dynamics of blood coagulation to create innovative materials that perform new functions inside of blood vessels\, and work to develop treatments for severe hemorrhage. \nDr. Kastrup has received many accolades\, the most recent one being the Sir Major Banting Award from the True Patriot Love Foundation. He is the Chief Scientific Officer of CoMotion Drug Delivery Systems\, Inc.\, which is working to develop hemostatic agents for severe combat and surgical hemorrhage.
URL:https://scienceinvancouver.com/event/lipid-and-rna-nanomedicines-to-control-bleeding-and-thrombosis-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T110000
DTSTAMP:20260404T185317
CREATED:20210908T224214Z
LAST-MODIFIED:20210908T224214Z
UID:32589-1632218400-1632222000@scienceinvancouver.com
SUMMARY:Lipid and RNA Nanomedicines to Control Bleeding and Thrombosis
DESCRIPTION:Dr. Christian Kastrup \nAssociate Professor in the Michael Smith Laboratories and Department of Biochemistry & Molecular Biology at the University of British Columbia; member of the Centre for Blood Research and the School of Biomedical Engineering \nTuesday 21 September 2021 \n10:00 – 11:00 am PDT | 1:00 – 2:00 pm EDT \nThis lecture will be delivered online using Zoom \nBlood coagulation is necessary to stop bleeds\, but an imbalance of the enzymes that form\, inhibit and degrade blood clots can lead to bleeding disorders\, failure to stop severe hemorrhage after injury\, or formation of thromboses. Gene therapy\, using RNA and lipid nanoparticles\, can be used to modulate the concentration of these enzymes and correct any imbalance. This talk will highlight the applicability of RNA and lipid nanoparticles to control the expression of endogenous and exogenous proteins in the liver and in platelets\, for the goal of creating useful therapies for trauma\, rare bleeding disorders\, and thrombosis. \nDr. Christian Kastrup did his postdoctoral fellowship in at MIT\, where he specialized in engineering biomaterials for cardiovascular drug delivery. He received his PhD at the University of Chicago\, where he specialized in chemical biology\, microfluidics\, and blood coagulation. His lab at UBC utilizes biochemical engineering to solve problems related to hemostasis and hemorrhage. They investigate\, utilize\, and mimic the biochemistry and biophysical dynamics of blood coagulation to create innovative materials that perform new functions inside of blood vessels\, and work to develop treatments for severe hemorrhage. \nDr. Kastrup has received many accolades\, the most recent one being the Sir Major Banting Award from the True Patriot Love Foundation. He is the Chief Scientific Officer of CoMotion Drug Delivery Systems\, Inc.\, which is working to develop hemostatic agents for severe combat and surgical hemorrhage.
URL:https://scienceinvancouver.com/event/lipid-and-rna-nanomedicines-to-control-bleeding-and-thrombosis-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T160000
DTSTAMP:20260404T185317
CREATED:20210716T221747Z
LAST-MODIFIED:20210823T212314Z
UID:17426-1632218400-1632240000@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:TUESDAY\, SEPTEMBER 21ST\, 2021 | 10 AM – 4 PM | ZOOM\n\n\n\n\n\n\n\nRegistration Deadline: September 15\, 2021 | Abstract Deadline: August 1\, 2021 \nQUICK LINKS\n\n\nKeynote Speakers \n\n\nDay Schedule \n\n\nDeadlines
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/BCCancerResearchDay2021.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T160000
DTSTAMP:20260404T185317
CREATED:20210716T221747Z
LAST-MODIFIED:20210716T221747Z
UID:26414-1632218400-1632240000@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:TUESDAY\, SEPTEMBER 21ST\, 2021 | 10 AM – 4 PM | ZOOM\n\n\n\n\n\n\n\nRegistration Deadline: September 15\, 2021 | Abstract Deadline: August 1\, 2021 \nQUICK LINKS\n\n\nKeynote Speakers \n\n\nDay Schedule \n\n\nDeadlines
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-2-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/BCCancerResearchDay2021.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T160000
DTSTAMP:20260404T185317
CREATED:20210716T221747Z
LAST-MODIFIED:20210716T221747Z
UID:28029-1632218400-1632240000@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:TUESDAY\, SEPTEMBER 21ST\, 2021 | 10 AM – 4 PM | ZOOM\n\n\n\n\n\n\n\nRegistration Deadline: September 15\, 2021 | Abstract Deadline: August 1\, 2021 \nQUICK LINKS\n\n\nKeynote Speakers \n\n\nDay Schedule \n\n\nDeadlines
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-2-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/BCCancerResearchDay2021.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T160000
DTSTAMP:20260404T185317
CREATED:20210716T221747Z
LAST-MODIFIED:20210716T221747Z
UID:31112-1632218400-1632240000@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:TUESDAY\, SEPTEMBER 21ST\, 2021 | 10 AM – 4 PM | ZOOM\n\n\n\n\n\n\n\nRegistration Deadline: September 15\, 2021 | Abstract Deadline: August 1\, 2021 \nQUICK LINKS\n\n\nKeynote Speakers \n\n\nDay Schedule \n\n\nDeadlines
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-2-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/BCCancerResearchDay2021.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210921T100000
DTEND;TZID=America/Vancouver:20210921T160000
DTSTAMP:20260404T185317
CREATED:20210716T221747Z
LAST-MODIFIED:20210716T221747Z
UID:32572-1632218400-1632240000@scienceinvancouver.com
SUMMARY:BC Cancer Research Day
DESCRIPTION:TUESDAY\, SEPTEMBER 21ST\, 2021 | 10 AM – 4 PM | ZOOM\n\n\n\n\n\n\n\nRegistration Deadline: September 15\, 2021 | Abstract Deadline: August 1\, 2021 \nQUICK LINKS\n\n\nKeynote Speakers \n\n\nDay Schedule \n\n\nDeadlines
URL:https://scienceinvancouver.com/event/bc-cancer-research-day-2-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/08/BCCancerResearchDay2021.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210922T100000
DTEND;TZID=America/Vancouver:20210922T110000
DTSTAMP:20260404T185317
CREATED:20210908T225440Z
LAST-MODIFIED:20210908T225440Z
UID:18221-1632304800-1632308400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research and Knowledge Translation in Arthritis Rehabilitation
DESCRIPTION:Linda C. Li\, PhD\, M.Sc.\, B.Sc. (PT)\nScientist\, CHÉOS \nProfessor\, Department of Physical Therapy\, Faculty of Medicine\, UBC\nCanada Research Chair in Patient-Oriented Knowledge Translation\nHarold Robinson/Arthritis Society Chair in Arthritic Diseases\, UBC\nSenior Scientist\, Arthritis Research Canada \nBillions of dollars have been invested globally in health research\, but the knowledge is unlikely to translate into health benefits if it is not being used in clinical practice or by individuals to inform their action. The purpose of this presentation is to discuss recent research that aims to modernize arthritis rehabilitation and improve the health of people with arthritis. \nThis presentation consists of two parts. First\, Dr. Li will discuss recent research on digital tools for promoting physical activity in people with arthritis. Second\, she will provide examples of involving patient partners in the development\, evaluation\, and knowledge translation of these tools. A new framework will be introduced to guide the process of meaningful patient engagement in the research process. \nThis talk is open and registration is required. It is part of our Work in Progress Seminar Series.
URL:https://scienceinvancouver.com/event/patient-oriented-research-and-knowledge-translation-in-arthritis-rehabilitation/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210922T100000
DTEND;TZID=America/Vancouver:20210922T110000
DTSTAMP:20260404T185317
CREATED:20210908T225440Z
LAST-MODIFIED:20210908T225440Z
UID:26434-1632304800-1632308400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research and Knowledge Translation in Arthritis Rehabilitation
DESCRIPTION:Linda C. Li\, PhD\, M.Sc.\, B.Sc. (PT)\nScientist\, CHÉOS \nProfessor\, Department of Physical Therapy\, Faculty of Medicine\, UBC\nCanada Research Chair in Patient-Oriented Knowledge Translation\nHarold Robinson/Arthritis Society Chair in Arthritic Diseases\, UBC\nSenior Scientist\, Arthritis Research Canada \nBillions of dollars have been invested globally in health research\, but the knowledge is unlikely to translate into health benefits if it is not being used in clinical practice or by individuals to inform their action. The purpose of this presentation is to discuss recent research that aims to modernize arthritis rehabilitation and improve the health of people with arthritis. \nThis presentation consists of two parts. First\, Dr. Li will discuss recent research on digital tools for promoting physical activity in people with arthritis. Second\, she will provide examples of involving patient partners in the development\, evaluation\, and knowledge translation of these tools. A new framework will be introduced to guide the process of meaningful patient engagement in the research process. \nThis talk is open and registration is required. It is part of our Work in Progress Seminar Series.
URL:https://scienceinvancouver.com/event/patient-oriented-research-and-knowledge-translation-in-arthritis-rehabilitation-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210922T100000
DTEND;TZID=America/Vancouver:20210922T110000
DTSTAMP:20260404T185317
CREATED:20210908T225440Z
LAST-MODIFIED:20210908T225440Z
UID:28049-1632304800-1632308400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research and Knowledge Translation in Arthritis Rehabilitation
DESCRIPTION:Linda C. Li\, PhD\, M.Sc.\, B.Sc. (PT)\nScientist\, CHÉOS \nProfessor\, Department of Physical Therapy\, Faculty of Medicine\, UBC\nCanada Research Chair in Patient-Oriented Knowledge Translation\nHarold Robinson/Arthritis Society Chair in Arthritic Diseases\, UBC\nSenior Scientist\, Arthritis Research Canada \nBillions of dollars have been invested globally in health research\, but the knowledge is unlikely to translate into health benefits if it is not being used in clinical practice or by individuals to inform their action. The purpose of this presentation is to discuss recent research that aims to modernize arthritis rehabilitation and improve the health of people with arthritis. \nThis presentation consists of two parts. First\, Dr. Li will discuss recent research on digital tools for promoting physical activity in people with arthritis. Second\, she will provide examples of involving patient partners in the development\, evaluation\, and knowledge translation of these tools. A new framework will be introduced to guide the process of meaningful patient engagement in the research process. \nThis talk is open and registration is required. It is part of our Work in Progress Seminar Series.
URL:https://scienceinvancouver.com/event/patient-oriented-research-and-knowledge-translation-in-arthritis-rehabilitation-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210922T100000
DTEND;TZID=America/Vancouver:20210922T110000
DTSTAMP:20260404T185317
CREATED:20210908T225440Z
LAST-MODIFIED:20210908T225440Z
UID:31132-1632304800-1632308400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research and Knowledge Translation in Arthritis Rehabilitation
DESCRIPTION:Linda C. Li\, PhD\, M.Sc.\, B.Sc. (PT)\nScientist\, CHÉOS \nProfessor\, Department of Physical Therapy\, Faculty of Medicine\, UBC\nCanada Research Chair in Patient-Oriented Knowledge Translation\nHarold Robinson/Arthritis Society Chair in Arthritic Diseases\, UBC\nSenior Scientist\, Arthritis Research Canada \nBillions of dollars have been invested globally in health research\, but the knowledge is unlikely to translate into health benefits if it is not being used in clinical practice or by individuals to inform their action. The purpose of this presentation is to discuss recent research that aims to modernize arthritis rehabilitation and improve the health of people with arthritis. \nThis presentation consists of two parts. First\, Dr. Li will discuss recent research on digital tools for promoting physical activity in people with arthritis. Second\, she will provide examples of involving patient partners in the development\, evaluation\, and knowledge translation of these tools. A new framework will be introduced to guide the process of meaningful patient engagement in the research process. \nThis talk is open and registration is required. It is part of our Work in Progress Seminar Series.
URL:https://scienceinvancouver.com/event/patient-oriented-research-and-knowledge-translation-in-arthritis-rehabilitation-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210922T100000
DTEND;TZID=America/Vancouver:20210922T110000
DTSTAMP:20260404T185317
CREATED:20210908T225440Z
LAST-MODIFIED:20210908T225440Z
UID:32592-1632304800-1632308400@scienceinvancouver.com
SUMMARY:Patient-Oriented Research and Knowledge Translation in Arthritis Rehabilitation
DESCRIPTION:Linda C. Li\, PhD\, M.Sc.\, B.Sc. (PT)\nScientist\, CHÉOS \nProfessor\, Department of Physical Therapy\, Faculty of Medicine\, UBC\nCanada Research Chair in Patient-Oriented Knowledge Translation\nHarold Robinson/Arthritis Society Chair in Arthritic Diseases\, UBC\nSenior Scientist\, Arthritis Research Canada \nBillions of dollars have been invested globally in health research\, but the knowledge is unlikely to translate into health benefits if it is not being used in clinical practice or by individuals to inform their action. The purpose of this presentation is to discuss recent research that aims to modernize arthritis rehabilitation and improve the health of people with arthritis. \nThis presentation consists of two parts. First\, Dr. Li will discuss recent research on digital tools for promoting physical activity in people with arthritis. Second\, she will provide examples of involving patient partners in the development\, evaluation\, and knowledge translation of these tools. A new framework will be introduced to guide the process of meaningful patient engagement in the research process. \nThis talk is open and registration is required. It is part of our Work in Progress Seminar Series.
URL:https://scienceinvancouver.com/event/patient-oriented-research-and-knowledge-translation-in-arthritis-rehabilitation-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR